ASO Author Reflections: Toward Better Outcomes in Poorly Differentiated Thyroid Cancer: Evaluating Adjuvant Radiotherapy, Treatment-related Morbidity, and Future Therapeutic Directions
- PMID: 40634810
- DOI: 10.1245/s10434-025-17725-8
ASO Author Reflections: Toward Better Outcomes in Poorly Differentiated Thyroid Cancer: Evaluating Adjuvant Radiotherapy, Treatment-related Morbidity, and Future Therapeutic Directions
Conflict of interest statement
Declarations. Conflicts of interest: The authors declare no conflicts of interest.
Similar articles
-
ASO Author Reflections: Refining Prognostic Staging in De Novo Metastatic Breast Cancer: Validation, Limitations, and Future Directions.Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18113-y. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40849372 No abstract available.
-
ASO Author Reflections: Improving Urothelial Carcinoma Outcomes: The Powerful Combination of Neoadjuvant and Adjuvant Chemotherapy in the Perioperative Period.Ann Surg Oncol. 2025 Aug;32(8):6187-6188. doi: 10.1245/s10434-025-17258-0. Epub 2025 May 19. Ann Surg Oncol. 2025. PMID: 40388027 No abstract available.
-
ASO Author Reflections: Shifting the Focus of pT1-2pN1 Breast Cancer: Are We Evaluating the Right Endpoint in Tailoring Adjuvant Radiation Therapy Recommendations?Ann Surg Oncol. 2018 Dec;25(Suppl 3):681-682. doi: 10.1245/s10434-018-6986-4. Epub 2018 Oct 30. Ann Surg Oncol. 2018. PMID: 30377922 No abstract available.
-
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.Cochrane Database Syst Rev. 2012 Mar 14;3(3):CD004706. doi: 10.1002/14651858.CD004706.pub4. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2015 Dec 17;(12):CD004706. doi: 10.1002/14651858.CD004706.pub5. PMID: 22419298 Free PMC article. Updated.
-
Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.Cochrane Database Syst Rev. 2016 Dec 11;12(12):CD010963. doi: 10.1002/14651858.CD010963.pub2. Cochrane Database Syst Rev. 2016. PMID: 27943254 Free PMC article.
References
-
- Ibrahimpasic T, Ghossein R, Carlson DL, et al. Outcomes in Patients With Poorly Differentiated Thyroid Carcinoma. J Clin Endocrinol Metab. 2014;99(4):1245–52. https://doi.org/10.1210/jc.2013-3842 . - DOI - PubMed
-
- Lee DY, Won JK, Choi HS, et al. Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma. Thyroid. 2016;26(9):1259–68. https://doi.org/10.1089/thy.2016.0147 . - DOI - PubMed
-
- Jonker PKC, Koetje JH, Turchini J, et al. Adjuvant External Beam Radiotherapy Reduces Local Recurrence in Poorly Differentiated Thyroid Cancer. Ann Surg Oncol. 2025. https://doi.org/10.1245/s10434-025-17434-2 . - DOI - PubMed
-
- Jonker PKC, Turchini J, Kruijff S, et al. Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment. Ann Surg Oncol. 2021;28(12):7520–30. https://doi.org/10.1245/s10434-021-10146-3 . - DOI - PubMed
-
- Jonker PKC. De-escalate if possible, intensify when needed: The good, the bad and the ugly: new insights into the full spectrum of thyroid cancer management. Chapter 10; Summary, general discussion and future perspectives. 2025; [Thesis fully internal (DIV), University of Groningen]. University of Groningen. https://doi.org/10.33612/diss.1289645453
LinkOut - more resources
Full Text Sources